or Try an Advanced Search...

    Technical Analysis for PEPG - PepGen Inc.

    Grade Last Price % Change Price Change
    F 4.40 -1.57% -0.07
    PEPG closed down 1.57 percent on Wednesday, November 20, 2024, on 52 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PEPG trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Slingshot Bearish Bearish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Bullish Engulfing Bullish -1.57%
    Outside Day Range Expansion -1.57%
    Wide Bands Range Expansion -1.57%
    Oversold Stochastic Weakness -1.57%
    Spinning Top Other 6.54%
    Older End-of-Day Signals for PEPG ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 22 hours ago
    10 DMA Resistance about 22 hours ago
    Up 5% about 22 hours ago
    Up 3% about 22 hours ago
    Up 2% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PEPG Chart by TradingView
    Basic chart:

    Profile

    PepGen, Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Deliver Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the root cause of serious diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Molecular Biology Cell Biology Peptides Oligonucleotide Nucleic Acids

    Is PEPG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 PepGen GAAP EPS of -$0.66 beats by $0.21
    Nov 7 PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 4 PepGen to Participate in Upcoming Investor Conferences
    Oct 1 Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
    Sep 19 PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors
    Aug 20 PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development
    Aug 20 PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development
    Aug 9 PepGen GAAP EPS of -$0.87
    Aug 8 PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
    Aug 2 Down -39.63% in 4 Weeks, Here's Why You Should You Buy the Dip in PepGen
    See more PEPG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.298
    52 Week Low 4.0
    Average Volume 101,842
    200-Day Moving Average 12.26
    50-Day Moving Average 7.76
    20-Day Moving Average 5.91
    10-Day Moving Average 4.63
    Average True Range 0.56
    RSI (14) 24.24
    ADX 45.18
    +DI 15.02
    -DI 35.89
    Chandelier Exit (Long, 3 ATRs) 7.19
    Chandelier Exit (Short, 3 ATRs) 5.67
    Upper Bollinger Bands 8.63
    Lower Bollinger Band 3.19
    Percent B (%b) 0.22
    BandWidth 92.11
    MACD Line -1.12
    MACD Signal Line -1.03
    MACD Histogram -0.0935
    Fundamentals Value
    Market Cap 104.78 Million
    Num Shares 23.8 Million
    EPS -2.73
    Price-to-Earnings (P/E) Ratio -1.61
    Price-to-Sales 0.00
    Price-to-Book 2.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.18
    Resistance 3 (R3) 5.22 5.00 5.05
    Resistance 2 (R2) 5.00 4.80 4.98 5.01
    Resistance 1 (R1) 4.70 4.67 4.59 4.66 4.97
    Pivot Point 4.47 4.47 4.42 4.46 4.47
    Support 1 (S1) 4.18 4.27 4.06 4.14 3.83
    Support 2 (S2) 3.95 4.15 3.93 3.79
    Support 3 (S3) 3.65 3.95 3.75
    Support 4 (S4) 3.62